Treatment efficacy of azithromycin 1g versus seven days doxycycline for the treatment of rectal chlamydia among men who have sex with men – a double-blind randomized controlled trial
Not Applicable
Completed
- Conditions
- Chlamydia trachomatisInfection - Sexually transmitted infections
- Registration Number
- ACTRN12614001125617
- Lead Sponsor
- niversity of Melbourne
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Male
- Target Recruitment
- 625
Inclusion Criteria
Consecutive English-speaking men aged 16 years or older, with rectal chlamydia meeting the eligibility criteria will be recruited and followed up for 4 weeks.
Inclusion criteria
* Men who report male to male sexual contact and are aged 16 years or older who test positive for rectal chlamydia using a Nucleic Acid Amplification Test (NAAT).
* Adequate English and comprehension skills to give informed consent
Exclusion Criteria
Men will be excluded:
i. they present with proctitis/other symptoms.
ii. are concurrently diagnosed with another bacterial STI
iii. Self-reported use of antibiotics in the last 2 weeks
iv. Known contraindications to the use of azithromycin or doxycycline including allergy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method